Genflow Biosciences PLC Announces Preliminary Interim Results From Dog Study
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET...
Dissolution-Instrument-Based Strategies to De-Risk and Accelerate Pharmaceutical DevelopmentWEST LAFAYETTE, Ind., Feb. 11, 2026 /PRNewswire/ -- Improved Pharma, a leader in...